高级检索
当前位置: 首页 > 详情页

Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2.

文献详情

资源类型:
Pubmed体系:
机构: [1]Ben May Department for Cancer Research, The University of Chicago, Chicago,IL, USA [2]Department of Pharmaceutical and Biomedical Sciences, University ofGeorgia, Athens, GA, USA [3]College of Pharmacy, Research Institute ofPharmaceutical Sciences, Kyungpook National University, Daegu, South Korea [4]Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada [5]Department of Biological Chemistry and Pharmacology, The Ohio StateUniversity, Columbus, OH, USA [6]CNRS UMR 5309, INSERM, U1209, UniversitéGrenoble Alpes, Institute for Advanced Biosciences, Grenoble, France [7]Shanghai Institute of Materia Medica, Chinese Academy of Sciences,Shanghai, China [8]Department of General Practice, State KeyLaboratory of Biotherapy, West China Hospital, Sichuan University, andCollaborative Innovation Center of Biotherapy, Chengdu, China
出处:
ISSN:

摘要:
Histone lysine crotonylation is a posttranslational modification with demonstrated functions in transcriptional regulation. Here we report the discovery of a new type of histone posttranslational modification, lysine methacrylation (Kmea), corresponding to a structural isomer of crotonyllysine. We validate the identity of this modification using diverse chemical approaches and further confirm the occurrence of this type of histone mark by pan specific and site-specific anti-methacryllysine antibodies. In total, we identify 27 Kmea modified histone sites in HeLa cells using affinity enrichment with a pan Kmea antibody and mass spectrometry. Subsequent biochemical studies show that histone Kmea is a dynamic mark, which is controlled by HAT1 as a methacryltransferase and SIRT2 as a de-methacrylase. Altogether, these investigations uncover a new type of enzyme-catalyzed histone modification and suggest that methacrylyl-CoA generating metabolism is part of a growing number of epigenome-associated metabolic pathways.© 2021. The Author(s).

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 1 区 生物学
小类 | 1 区 细胞生物学
最新[2023]版:
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
第一作者:
第一作者机构: [1]Ben May Department for Cancer Research, The University of Chicago, Chicago,IL, USA
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号